News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
765,594 Results
Type
Article (51412)
Company Profile (296)
Press Release (713870)
Multimedia
Podcasts (106)
Webinars (20)
Section
Business (212952)
Career Advice (2121)
Deals (36683)
Drug Delivery (134)
Drug Development (84093)
Employer Resources (174)
FDA (17301)
Job Trends (15832)
News (360899)
Policy (34930)
Tag
2027 BioCapital Elite (1)
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (4)
Academia (2819)
Accelerated approval (43)
Adcomms (30)
Allergies (170)
Alliances (51763)
ALS (201)
Alzheimer's disease (1822)
Antibody-drug conjugate (ADC) (401)
Approvals (17634)
Artificial intelligence (644)
Autoimmune disease (243)
Automation (52)
Bankruptcy (375)
Best Places to Work (12096)
BIOSECURE Act (20)
Biosimilars (208)
Biotechnology (190)
Bladder cancer (181)
Brain cancer (69)
Breast cancer (713)
Cancer (5550)
Cardiovascular disease (473)
Career advice (1806)
Career pathing (44)
CAR-T (310)
CDC (60)
Celiac Disease (2)
Cell therapy (824)
Cervical cancer (45)
Clinical research (72360)
Collaboration (2021)
Company closure (4)
Compensation (1309)
Complete response letters (77)
COVID-19 (2860)
CRISPR (101)
C-suite (1057)
Cystic fibrosis (150)
Data (7273)
Decentralized trials (3)
Denatured (38)
Depression (165)
Dermatology (70)
Diabetes (567)
Diagnostics (7079)
Digital health (55)
Diversity (13)
Diversity, equity & inclusion (46)
Drug discovery (304)
Drug pricing (206)
Drug shortages (34)
Duchenne muscular dystrophy (270)
Earnings (93356)
Editorial (66)
Employer branding (21)
Employer resources (153)
Events (123757)
Executive appointments (1075)
FDA (20893)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (33)
Funding (1690)
Gene editing (219)
Generative AI (62)
Gene therapy (671)
GLP-1 (1094)
Government (4996)
Grass and pollen (6)
Guidances (402)
Healthcare (20046)
HIV (78)
Huntington's disease (53)
IgA nephropathy (93)
Immunology and inflammation (284)
Immuno-oncology (88)
Indications (164)
Infectious disease (3194)
Inflammatory bowel disease (210)
Inflation Reduction Act (14)
Influenza (136)
Intellectual property (279)
Interviews (324)
IPO (17020)
IRA (51)
Job creations (4061)
Job search strategy (1509)
JPM (58)
Kidney cancer (18)
Labor market (94)
Layoffs (577)
Leadership (37)
Legal (8510)
Liver cancer (102)
Longevity (30)
Lung cancer (746)
Lymphoma (414)
Machine learning (55)
Management (59)
Manufacturing (973)
MASH (185)
Medical device (14912)
Medtech (14998)
Mergers & acquisitions (20851)
Metabolic disorders (1487)
mRNA (189)
Multiple sclerosis (178)
NASH (17)
Neurodegenerative disease (405)
Neuropsychiatric disorders (103)
Neuroscience (3289)
Neurotech (1)
NextGen: Class of 2026 (6922)
Non-profit (4786)
Now hiring (74)
Obesity (708)
Opinion (298)
Ovarian cancer (199)
Pain (241)
Pancreatic cancer (271)
Parkinson's disease (358)
Partnered (34)
Patents (568)
Patient recruitment (633)
Peanut (62)
People (62262)
Pharmaceutical (65)
Pharmacy benefit managers (33)
Phase 1 (22523)
Phase 2 (31783)
Phase 3 (23728)
Pipeline (7502)
Policy (316)
Postmarket research (2744)
Preclinical (9588)
Press Release (67)
Prostate cancer (286)
Psychedelics (52)
Radiopharmaceuticals (321)
Rare diseases (1033)
Real estate (6360)
Recruiting (70)
Regulatory (26578)
Reports (54)
Research institute (2575)
Resumes & cover letters (363)
Rett syndrome (33)
RNA editing (17)
RSV (90)
Schizophrenia (175)
Series A (277)
Series B (210)
Service/supplier (12)
Sickle cell disease (109)
Special edition (22)
Spinal muscular atrophy (169)
Sponsored (47)
Startups (3883)
State (2)
Stomach cancer (19)
Supply chain (131)
Tariffs (90)
The Weekly (66)
Vaccines (1117)
Venture capital (101)
Weight loss (469)
Women's health (118)
Worklife (20)
Date
Today (148)
Last 7 days (585)
Last 30 days (2679)
Last 365 days (30793)
2026 (9127)
2025 (30909)
2024 (36103)
2023 (41145)
2022 (52383)
2021 (57101)
2020 (55911)
2019 (48795)
2018 (36938)
2017 (33746)
2016 (33564)
2015 (39609)
2014 (33325)
2013 (28558)
2012 (30846)
2011 (31551)
2010 (29924)
Location
Africa (817)
Alabama (93)
Alaska (7)
Arizona (343)
Arkansas (16)
Asia (42749)
Australia (7046)
California (12570)
Canada (3590)
China (1307)
Colorado (551)
Connecticut (557)
Delaware (382)
Europe (93144)
Florida (1896)
Georgia (411)
Hawaii (3)
Idaho (66)
Illinois (1045)
India (84)
Indiana (581)
Iowa (22)
Japan (512)
Kansas (132)
Kentucky (48)
Louisiana (39)
Maine (75)
Maryland (1550)
Massachusetts (9059)
Michigan (360)
Minnesota (711)
Mississippi (7)
Missouri (144)
Montana (33)
Nebraska (29)
Nevada (142)
New Hampshire (89)
New Jersey (3376)
New Mexico (30)
New York (3332)
North Carolina (1672)
North Dakota (8)
Northern California (6221)
Ohio (376)
Oklahoma (24)
Oregon (42)
Pennsylvania (2542)
Puerto Rico (28)
Rhode Island (52)
South America (1201)
South Carolina (83)
South Dakota (2)
Southern California (4945)
Tennessee (204)
Texas (2013)
United States (44975)
Utah (378)
Vermont (1)
Virginia (301)
Washington D.C. (83)
Washington State (1040)
West Virginia (4)
Wisconsin (129)
Wyoming (2)
765,594 Results for "aethlon medical inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Aethlon Medical, Inc. Advances to Final Cohort in Oncology Clinical Trial Following Positive DSMB Review
March 24, 2026
·
6 min read
Press Releases
Aethlon Medical Engages Maxim Group LLC to Evaluate Strategic Opportunities
March 12, 2026
·
5 min read
Press Releases
Aethlon Medical Announces Fiscal Q3 2026 Financial Results and Corporate Update
February 12, 2026
·
12 min read
Press Releases
Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 12, 2026
February 5, 2026
·
3 min read
Press Releases
Aethlon Medical Announces Fiscal Q2 2025 Financial Results and Corporate Update
November 13, 2025
·
14 min read
Press Releases
Aethlon Medical to Release Fiscal Second Quarter Financial Results and Host Conference Call on November 12, 2025
November 10, 2025
·
3 min read
Press Releases
Aethlon Medical Announces Pricing of a Private Placement and Warrant Inducement, Priced At-The-Market for Aggregate Gross Proceeds of $3.3 Million
December 8, 2025
·
6 min read
Press Releases
Aethlon Medical Announces Pricing of $4.5 Million Public Offering
September 5, 2025
·
5 min read
Press Releases
Aethlon Medical, Inc. Announces Positive Data Safety Monitoring Board Review and Recommendation to Advance to Next Clinical Trial Cohort
July 16, 2025
·
5 min read
Press Releases
Aethlon Medical Announces Publication of Preclinical Data Showing That the GNA Affinity Resin in the Hemopurifier® Binds to Extracellular Vesicles in Long COVID patient samples and Decreases Inflammatory microRNAs
December 3, 2025
·
7 min read
1 of 76,560
Next
